Avalo Therapeutics, Inc.
—- Market cap
- $976.60M
- Debt
- —
- Cash
- −$15.86M
Complete market value, debt and cash evidence is required for enterprise value.
Quick read
Fair value engine
Each company valued on the other's multiple, then compared with the market price.
AVTX · price snapshotP/S 16552.58x
$18.21Snapshot Sep 9, 2026, 4:00 PM ET
Implied fair value · at NFE's multiple
$0.00100.0% below market
0.00 AVTX revenue / share×0.05x NFE P/S=$0.00
Market $18.21Implied $0.00
NFE · price snapshotP/S 0.05x
$0.27Snapshot Sep 9, 2026, 4:00 PM ET
Implied fair value · at AVTX's multiple
$87,159.2131,961,472.2% above market
5.27 NFE revenue / share×16552.58x AVTX P/S=$87,159.21
Market $0.27Implied $87,159.21